Comment
doi: 10.7326/0003-4819-159-6-201309170-02009.
Meta-analysis: selective estrogen-receptor modulators reduce breast cancer incidence
- PMID: 24042392
- DOI: 10.7326/0003-4819-159-6-201309170-02009
Item in Clipboard
Comment
Meta-analysis: selective estrogen-receptor modulators reduce breast cancer incidence
Ann Intern Med.
.
No abstract available
Comment on
-
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.Lancet. 2013 May 25;381(9880):1827-34. doi: 10.1016/S0140-6736(13)60140-3. Epub 2013 Apr 30. Lancet. 2013. PMID: 23639488 Free PMC article. Review.
Similar articles
-
Breast cancer prevention: SERMs come of age.Lancet. 2013 May 25;381(9880):1795-7. doi: 10.1016/S0140-6736(13)60443-2. Epub 2013 Apr 30. Lancet. 2013. PMID: 23639489 No abstract available.
-
Arzoxifene: a promising new selective estrogen receptor modulator for clinical chemoprevention of breast cancer.Clin Cancer Res. 2004 Aug 15;10(16):5313-5. doi: 10.1158/1078-0432.CCR-04-1377. Clin Cancer Res. 2004. PMID: 15328166 Review. No abstract available.
-
Raloxifene works as well as tamoxifen in preventing invasive breast cancer.Mayo Clin Womens Healthsource. 2006 Oct;10(10):3. Mayo Clin Womens Healthsource. 2006. PMID: 16977270 No abstract available.
-
Raloxifene examined for breast cancer prevention.Am J Health Syst Pharm. 2007 Sep 1;64(17):1774. doi: 10.2146/news070075. Am J Health Syst Pharm. 2007. PMID: 17724350 No abstract available.
-
SERMs in chemoprevention of breast cancer.Eur J Cancer. 2005 Sep;41(13):1980-9. doi: 10.1016/j.ejca.2005.04.017. Eur J Cancer. 2005. PMID: 15964182 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
